UCM-05194

UCM-05194 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354; +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:UCM-05194
CAS:2411412-36-5
Purity:91.22% Package:1mg;333USD|5mg;790USD|10mg;1120USD
Company Name: NANJING YINGWEN BIOTECHNOLOGY CO LTD
Tel: +8613382787392
Email: sales@aeechem.com
Products Intro: CAS:2411412-36-5
Purity:98%
Company Name: Nantong QuanYi Biotechnology Co., Ltd  
Tel: 0513-66337626 18051384581
Email: sales@chemhifuture.com
Products Intro: Product Name:UCM-05194
CAS:2411412-36-5
Purity:98%HPLC Package:10mg,100mg,500mg,1g,2g,5g,10g,more
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Email: customer_service@efebio.com
Products Intro: Product Name:UCM-05194
CAS:2411412-36-5
Purity:95% Package:1mg;2mg;5mg
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:UCM-05194
CAS:2411412-36-5
Package:1mg/RMB 2330;5mg/RMB 5630;10mg/RMB 7880

UCM-05194 manufacturers

  • UCM-05194
  • UCM-05194 pictures
  • $333.00 / 1mg
  • 2026-04-20
  • CAS:2411412-36-5
  • Min. Order:
  • Purity: 98.00%
  • Supply Ability: 10g
UCM-05194 Basic information
Product Name:UCM-05194
Synonyms:Benzenedecanoic acid, (1S)-1-(bromomethyl)-2-(phosphonooxy)ethyl ester
CAS:2411412-36-5
MF:C19H30BrO6P
MW:465.32
EINECS:
Product Categories:
Mol File:2411412-36-5.mol
UCM-05194 Structure
UCM-05194 Chemical Properties
Boiling point 582.891±60.00 °C(Press: 760.00 Torr)(predicted)
density 1.343±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka1.762±0.10(predicted)
Safety Information
MSDS Information
UCM-05194 Usage And Synthesis
UsesUCM-05194 is a selective LPA1 receptor agonist with activity to improve neuropathic pain. UCM-05194 is a LPA1 agonist that exhibits potent and selective properties in its pharmacologically similar properties. UCM-05194 triggers LPA1-mediated cellular effects and leads to internalization of the receptor, resulting in functional inactivation in primary sensory neurons. UCM-05194 effectively reduces pain perception in in vivo models. UCM-05194 can be used to conduct research on progressive systemic diseases[1].
References[1] A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA1), UCM-05194, Shows Efficacy in Neuropathic Pain Amelioration
UCM-05194 Preparation Products And Raw materials
Tag:UCM-05194(2411412-36-5) Related Product Information